PAT seeks quality by design

The pharmaceutical industry responded to the FDA's cGMP report with Process Analytical Technology, or PAT, a system to design, analyze, and control manufacturing and packaging processes through timely measurements of critical quality and performance attributes. The goal of PAT is to understand and control the processes with the assumption that quality cannot be tested into products, but rather should be built into systems by design.